Literature DB >> 20387790

RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.

Jeppe B Madsen1, Daniel M Dupont, Thomas B Andersen, Anne F Nielsen, Lu Sang, Ditte M Brix, Jan K Jensen, Thomas Broos, Maarten L V Hendrickx, Anni Christensen, Jørgen Kjems, Peter A Andreasen.   

Abstract

The hallmark of serpins is the ability to undergo the so-called "stressed-to-relaxed" switch during which the surface-exposed reactive center loop (RCL) becomes incorporated as strand 4 in central beta-sheet A. RCL insertion drives not only the inhibitory reaction of serpins with their target serine proteases but also the conversion to the inactive latent state. RCL insertion is coupled to conformational changes in the flexible joint region flanking beta-sheet A. One interesting serpin is plasminogen activator inhibitor-1 (PAI-1), a fast and specific inhibitor of the serine proteases tissue-type and urokinase-type plasminogen activator. Via its flexible joints' region, native PAI-1 binds vitronectin and relaxed, protease-complexed PAI-1 certain endocytosis receptors. From a library of 35-nucleotides long 2'-fluoropyrimidine-containing RNA oligonucleotides, we have isolated two aptamers binding PAI-1 by the flexible joint region with low nanomolar K(D) values. One of the aptamers exhibited measurable binding to native PAI-1 only, while the other also bound relaxed PAI-1. While none of the aptamers inhibited the antiproteolytic effect of PAI-1, both aptamers inhibited vitronectin binding and the relaxed PAI-1-binding aptamer also endocytosis receptor binding. The aptamer binding exclusively to native PAI-1 increased the half-life for the latency transition to more than 6 h, manyfold more than vitronectin. Contact with Lys124 in the flexible joint region was critical for strong inhibition of the latency transition and the lack of binding to relaxed PAI-1. We conclude that aptamers yield important information about the serpin conformational switch and, because they can compete with high-affinity protein-protein interactions, may provide leads for pharmacological intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387790     DOI: 10.1021/bi100066j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains.

Authors:  René Bager; Thomas K Kristensen; Jan K Jensen; Agnieszka Szczur; Anni Christensen; Lisbeth M Andersen; Jesper S Johansen; Niels Larsen; Erik Baatrup; Mingdong Huang; Michael Ploug; Peter A Andreasen
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

2.  Next-generation sequencing as input for chemometrics in differential sensing routines.

Authors:  Sara Goodwin; Alexandra M Gade; Michelle Byrom; Baine Herrera; Camille Spears; Eric V Anslyn; Andrew D Ellington
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-31       Impact factor: 15.336

3.  Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.

Authors:  Stephanie Brandal; Charlene M Blake; Bruce A Sullenger; Yolanda M Fortenberry
Journal:  Nucleic Acid Ther       Date:  2011-11-21       Impact factor: 5.486

4.  Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers.

Authors:  Jared Damare; Stephanie Brandal; Yolanda M Fortenberry
Journal:  Nucleic Acid Ther       Date:  2014-06-12       Impact factor: 5.486

5.  Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.

Authors:  Daniel Miotto Dupont; Jeppe Buur Madsen; Roland Karl Hartmann; Bertrand Tavitian; Frédéric Ducongé; Jørgen Kjems; Peter André Andreasen
Journal:  RNA       Date:  2010-10-20       Impact factor: 4.942

6.  Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.

Authors:  Daniel M Dupont; Niels Larsen; Jan K Jensen; Peter A Andreasen; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2015-07-10       Impact factor: 16.971

Review 7.  Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers.

Authors:  Nam Nguyen Quang; Gérald Perret; Frédéric Ducongé
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-10

8.  Conformational preludes to the latency transition in PAI-1 as determined by atomistic computer simulations and hydrogen/deuterium-exchange mass spectrometry.

Authors:  Michael Petersen; Jeppe B Madsen; Thomas J D Jørgensen; Morten B Trelle
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

9.  Resolving distinct molecular origins for copper effects on PAI-1.

Authors:  Joel C Bucci; Carlee S McClintock; Yuzhuo Chu; Gregory L Ware; Kayla D McConnell; Joseph P Emerson; Cynthia B Peterson
Journal:  J Biol Inorg Chem       Date:  2017-09-14       Impact factor: 3.358

10.  Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.

Authors:  Yolanda M Fortenberry; Stephanie M Brandal; Gilles Carpentier; Malvi Hemani; Arvind P Pathak
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.